Sherene Loi, MBBS (Hons), PhD, FRACP, FAHMS 

I am a Medical Oncologist specialized in breast cancer treatment as well as a clinician scientist with expertise in genomics, immunology and drug development. I am recognised internationally as a leading clinician scientist whose work has led to new insights into the breast cancer immunology field. 

After completing Medical Oncology specialist clinical training in Melbourne, I undertook a PhD and postdoctoral studies at the Institut Jules Bordet in Brussels, Belgium. In 2013, I returned to a Group Leader position at the Peter MacCallum Cancer Centre in Melbourne, as well as Consultant Medical Oncologist in the Breast Service and head of the Breast Cancer Clinical Trials Unit. 

To date, I have published over 220 peer-reviewed research articles with a lifetime H index of 79. My recent work has been highly influential with 30,617 total citations and 23,711 (77%) within the past 5 years. I am ranked in the top 1% of highly cited researchers globally by the Web of Science. I am a Board Director as well as a member of the Scientific Advisory Committee of the Australia New Zealand Breast Cancer Trials Group (BCT Australia/NZ), which is the largest breast cancer clinical trials cooperative group in Australia. I Co-Chair the Scientific Executive Committee of the International Breast Cancer Study Group (IBCSG) based in Bern, Switzerland which conducts academic global breast cancer clinical trials in over 16 countries. I am the current holder of the Inaugural National Breast Cancer Foundation (NBCF) of Australia Endowed Chair and a research fellow of the Breast Cancer Research Foundation (BCRF), New York.